KYMR
Kymera TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
KYMR vs peer average
54/100
KYMR vs. peer average (C vs. C)
Grade spread
A 1 · B 1 · C 4 · D 4 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
COGT is the first available peer comparator.
Cogent Biosciences is a closer small-cap clinical biotech risk comparator than a business-model match; both trade on pipeline execution rather than commercial cash flow, so trial timing and readout quality matter more than quarterly revenue.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
KYMR
Kymera Therapeutics
COGT
Cogent Biosciences
Grade
C
F
Momentum
94
75
Value
41
41
Sentiment
28
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs COGT
KYMR / COGT
Grade Position
In line
KYMR vs. peer average (C vs. C)
54/100
Momentum
94
KYMRValue
41
KYMRSentiment
28
KYMRRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs KYMR
COGT is the first peer returned for this comparison set.